Lifespin

Lifespin GmbH, founded in 2017 and headquartered in Germany, specializes in creating an AI-based health testing platform for patient samples with metabolomics data mapping. The company's slogan, "Lifespin GmbH creates AI-based health testing platform for patient samples with metabolomics data mapping," reflects its core focus.

The cutting-edge data firm focuses on analyzing quantitative metabolic data in patient samples and transforming it into valuable health information for use in pharmaceutical, research, and clinical settings. Lifespin's expertise lies in the field of metabolomics mapping for human health, with applications spanning diagnostics, personalized medicine, patient stratification, and drug discovery process support.

The latest investment in Lifespin amounted to €2.50M in a Convertible Note investment on 13 December 2021, with the investment coming from Wieland Capital. This injection of capital is expected to further propel the company's efforts in revolutionizing health testing through AI technology and metabolomics data mapping in the healthcare industry.